Secretory Products of Breast Cancer Cells Specifically Affect Human Osteoblastic Cells: Partial Characterization of Active Factors
- 1 April 1997
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 12 (4) , 552-560
- https://doi.org/10.1359/jbmr.1997.12.4.552
Abstract
SCOPUS: ar.jFLWINinfo:eu-repo/semantics/publisheKeywords
This publication has 25 references indexed in Scilit:
- Effects of secretory products of breast cancer cells on osteoblast-like cellsBreast Cancer Research and Treatment, 1996
- Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysisJournal of Orthopaedic Research, 1996
- Breast cancer and boneCurrent Opinion in Endocrinology, Diabetes and Obesity, 1995
- Prognostic relevance of transforming growth factor alpha (TGF-α) and tumor necrosis factor alpha (TNF-α) detected in breast cancer tissues by immunohistochemistryBreast Cancer Research and Treatment, 1994
- Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.Journal of Clinical Investigation, 1993
- Effect of transforming growth factor β on parathyroid hormone receptor binding and cAMP formation in rat osteosarcoma cellsJournal of Bone and Mineral Research, 1992
- Adenylate cyclase stimulating activity immunologically similar to parathyroid hormone-related peptide can be extracted from fetal rat long bonesJournal of Bone and Mineral Research, 1991
- Mechanisms of osteolytic bone destructionBone, 1991
- Bone cell responsiveness to transforming growth factor β, parathyroid hormone, and prostaglandin E2 in normal and postmenopausal osteoporotic womenJournal of Bone and Mineral Research, 1990
- Transforming growth factor-β-induced mitogenesis of human bone cancer cellsBiochemical and Biophysical Research Communications, 1989